Clinical Research Directory
Browse clinical research sites, groups, and studies.
From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.
Sponsor: Babes-Bolyai University
Summary
The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Official title: From Fear to Purpose ACT Protocol: Testing Indirect, Transdiagnostic Implications of Death Anxiety Over Depression and Anxiety. A Randomized Placebo Controlled Trial.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
175
Start Date
2025-06-01
Completion Date
2025-12-30
Last Updated
2025-04-18
Healthy Volunteers
No
Conditions
Interventions
From Fear to Purpose (Acceptance and Commitment Therapy)
The From Fear to Purpose ACT Protocol is based on Acceptance and Commitment Therapy (ACT) strategies, build around identifying and committing to personal values. The intervention will be group-based (90 minutes session).
Placebo
The placebo condition consists of a group-based attentional control intervention.